All Stories

  1. Opening the Black Box: Reflections from the AJP-Lung Early Career Editorial Fellows
  2. The Evolving Pathophysiology of Bronchopulmonary Dysplasia
  3. Early Multiomic Signals of Severe Bronchopulmonary Dysplasia in Extremely Low Birthweight Premature Infants
  4. MicroRNA Let-7b-5p Is a Biomarker and Potential Therapeutic Target in Bronchopulmonary Dysplasia
  5. Senescence at the Crossroads of Lung Development and Injury
  6. The fungal microbiota modulate neonatal oxygen-induced lung injury
  7. A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation
  8. Mediators of Antenatal Inflammation Propagating Chronic Neonatal Lung Disease
  9. The IL-33/ST2-axis Contributes to the Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension
  10. Altered hepatic and intestinal homeostasis in a neonatal murine model of short-term total parenteral nutrition and antibiotics
  11. Antimicrobial peptides modulate lung injury by altering the intestinal microbiota
  12. Clinical trial of a probiotic and herbal supplement for lung health
  13. The fungal intestinal microbiota predict the development of bronchopulmonary dysplasia in very low birthweight newborns
  14. Clinical Trial of a Probiotic and Herbal Supplement for Lung and Gut Health
  15. Impact of total parenteral nutrition and antibiotics on hepatic and intestinal homeostasis in pediatric murine model
  16. The Fungal Intestinal Microbiota Predict the Development of Bronchopulmonary Dysplasia in Very Low Birthweight Newborns
  17. Antimicrobial peptides modulate lung injury by altering the intestinal microbiota
  18. Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics
  19. Association of mycoplasma and ureaplasma respiratory colonization and bronchopulmonary dysplasia in extremely preterm infants- a propensity score matched case-control study
  20. Clinical Trial of a Probiotic and Herbal Supplement for Lung and Gut Health
  21. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation
  22. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation
  23. Reply to Pantaleón García et al.
  24. Hyperoxia Exposure Produces Indirect Lung Injury by Altering Antimicrobial Peptide Production and the Microbiota of the Newborn Small Intestine
  25. Sa1655: PROBIOTIC AND HERBAL BLEND DECREASES MARKERS OF NEUTROPHILIC INFLAMMATION IN IN VITRO AND IN VIVO MODELS OF PROTEOBACTERIA-INDUCED DYSBIOSIS
  26. Dietary Lipid Oxidization Products Alter Growth, Adiposity and Gut Microbial Ecology in Prepubertal Porcine Model
  27. The gut microbiome of extremely preterm infants randomized to the early progression of enteral feeding
  28. Necrotizing enterocolitis and the gut-lung axis
  29. Hyperoxia Exposure in Neonatal Period Is Associated with Decrease in HB-EGF Expression in Mice Kidneys
  30. Toll-like receptors: shapers of the pulmonary microbiome?
  31. Chorioamnionitis and neonatal outcomes
  32. The Fungal Airway Mycobiome Predicts the Development of Bronchopulmonary Dysplasia
  33. The gut mycobiome influences the host's metabolism of processed food
  34. Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis
  35. The closed eye harbours a unique microbiome in dry eye disease
  36. The gut mycobiome of healthy mice is shaped by the environment and shapes metabolic outcomes in response to diet
  37. A stable cutaneous mycobiome exists from birth
  38. Fungal Airway Microbiome at Birth
  39. Variability in interkingdom gut microbiomes between different commercial vendors shapes fat gain in response to diet
  40. TGR5 signaling mitigates parenteral nutrition-associated liver disease
  41. Mice without a microbiome are partially protected from lung injury by hyperoxia
  42. The closed eye harbors a unique microbiome in dry eye disease
  43. 1174: IL-6 Knockout decreases severity of lung injury in an experimental model of bronchopulmonary dysplasia (BPD)
  44. 188: Absence of IL-6 does not decrease pulmonary inflammation in two models of bronchopulmonary dysplasia (BPD)
  45. Maternal Antibiotic Treatment May Harm Preemies’ Lungs
  46. Babies are born with fungi in their guts
  47. Maternal Peripartum Antibiotic Exposure Worsens Experimental Bronchopulmonary Dysplasia
  48. Fungi form interkingdom microbial communities in the primordial human gut that develop with gestational age
  49. The human primordial microbiome hosts complex bacterial and fungal interkingdom ecologies that vary with gestational age
  50. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia
  51. The death knell of inhaled nitric oxide to prevent bronchopulmonary dysplasia?
  52. Shaken or Stirred? Evaluating the combination of budesonide-surfactant for survival free of bronchopulmonary dysplasia
  53. Bariatric Surgery and the Pregnancy Complicated by Gestational Diabetes
  54. Pregnancy and neonatal outcome after bariatric surgery
  55. Bariatric surgery and pregnancy: the magical solution?
  56. Bariatric Surgery: Impact on Pregnancy Outcomes